What follows is a mildly dense post … Sharing the details functions, in part, as a demonstration for the rationale behind the trade that we are going to put on; digest too the position of the entity relative to its development continuum and that shall additionally illuminate the Company selection for our trade. We will [...]

• 778http://clsdf.com/2011/04/trade-prep-optimer-pharma-optr/Trade+Prep+-+Optimer+Pharma+%28OPTR%292011-04-26+20%3A29%3A33admin

Clostridium difficile infection (CDI), commonly referred to as “C. difficile” or “c-diff”, has become a significant medical problem in hospitals, long-term care facilities, and in the community and is estimated to afflict more than 700,000 people each year in the U.S. It is a serious illness resulting from infection of the inner lining of the [...]

• 772http://clsdf.com/2011/04/about-clostridium-difficile-infection/About+Clostridium+difficile+Infection2011-04-18+21%3A43%3A43admin